
CANNSUN RECEIVES REGULATORY APPROVAL FOR THE FIRST WOMEN’S FOCUSED PHASE II PSILOCYBIN TRIAL ON THE AFRICAN CONTINENT
CAPE TOWN, SOUTH AFRICA, April 14, 2022 /EINPresswire.com/ -- Cannsun Group PLC ("Cannsun"), a bio-pharmaceutical company focused on developing and commercializing new medicines to optimize human potential with operations in South Africa & …